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Nonenzymatic Glycosylation of
Erythrocyte Membrane Proteins
RELEVANCE TO DIABETES
JOHN A. MILLER, ELLEN GRAVALLESE, and H. FRANKLIN BUNN, Laboratory of the
Howard Hughes Medical Institute at Peter Bent Brigham Hospital, Harvard
Medical School, Boston, Massachusetts 02115
A B S T R A C T Nonenzymatic glycosylation of pro-
teins of the erythrocyte membrane was determined by
incubating erythrocyte ghosts with [3H]borohydride.
The incorporation of tritium into protein provides a
reliable assay of ketoamine linkages. The membrane
proteins from 18 patients with diabetes incorporated
twice as much radioactivity as membrane proteins from
normal erythrocytes. After acid hydrolysis, amino acid
analysis showed that the majority of radioactivity was
localized to glucosyllysine. Autoradiograms showed
that all of the major proteins of the erythrocyte mem-
brane, separated by electrophoresis on sodium dodecyl
sulfate gels, contained ketoamine linkages. No protein
bands in either normal or diabetic erythrocytes
showed significant preferential labeling. Erythrocyte
membranes from three patients with hemolytic anemia
showed reduced incorporation of tritium from [H]-
borohydride, indicating decreased nonenzymatic gly-
cosylation. Two patients with diabetes and hemolytic
anemia had incorporation of radioactivity similar to that
of normal individuals. In these groups of patients the
incorporation of tritium into erythrocyte membrane
proteins correlated with levels of hemoglobin Alc.
Thus the modification ofmembrane proteins like that of
hemoglobin depends on blood glucose levels as well as
erythrocyte age. These studies show that the enhanced
nonenzymatic glycosylation of proteins in diabetics
extends beyond hemoglobin to the proteins of the
erythrocyte membrane and probably affects other
proteins that have slow turnover and are exposed to
high concentrations of glucose.
INTRODUCTION
During the circulation of erythrocytes in vivo, hemo-
globin is slowly glycosylated. Glucose reacts non-
Received for publication 11 September 1979 and in revised
form 21 November 1979.
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enzymatically with the NH2-terminal residue of the
f3-chain (f3-NA1 valine) to form hemoglobin Al, (1-3).
Hemoglobin Al, is increased two- to threefold in pa-
tients with diabetes mellitus and provides a useful
assessment of blood glucose control (4-6). In addition,
glucose forms similar ketoamine linkages with the NH2-
terminus ofthe a-chain and with certain lysine residues
on the a- and ,8-chains (7). The glycosylation of lysine
residues on human hemoglobin is also increased in
patients with diabetes (7, 8). This type of post-
translational modification has been proposed in the
pathogenesis of the long-term complications of diabetes
(9, 10). Therefore, it is important to determine what
other proteins undergo nonenzymatic glycosylation.
Since the reaction is very slow, the most likely
candidates are proteins that have a long turnover time
and are exposed to concentrations of glucose compara-
ble to that in plasma. Glucose-lysine adducts have been
demonstrated in bovine collagen (11), human albumin
(12), and in the proteins of the human erythrocyte
membrane (13). Furthermore, preliminary evidence
indicates the presence of glucosyllysine in lens
crystallin (14) and basic myelin protein (15).
We have investigated nonenzymatic glycosylation of
the proteins of the human erythrocyte membrane. We
have determined the distribution of glucosyllysine
residues among the various membrane proteins of
normal erythrocytes as well as erythrocytes of patients
with diabetes and hemolytic anemia.
METHODS
Patient selection. All patients with diabetes mellitus had
two random serum glucose concentrations > 250 mg/100 ml,
were not receiving oral hypoglycemic agents, had no clinical
evidence of pancreatitis, had received no blood transfusions
within the previous 2 mo, and had hemoglobin concentrations
> 13 g/100 ml. In addition blood specimens were obtained
on three patients with various types ofhemolytic anemias and
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on two patients with diabetes and hemolytic anemia. Healthy
laboratory personnel served as controls.
Incubation of erythrocyte ghosts. Erythrocyte ghosts
were prepared according to the method of Dodge et al. (16)
from freshly drawn heparinized venous blood from 18 normal
individuals and 18 diabetic patients. Ghosts were stored
ovemight at 4°C in 5 mM sodium phosphate buffer pH 8.
Equivalent amounts of normal and diabetic ghosts were
incubated for 40 min at room temperature in 16 mM
[3H]sodium borohydride (New England Nuclear, Boston,
Mass.), adjusted to pH 7.4. Eight separate experiments were
performed. Experiments 1 and 2 employed 10 mCi [3H]-
NaBH4, whereas experiments 3 and 4 used 16 mCi, and
experiments 5-8 used 25 mCi. The labeled ghosts were
exhaustively dialysed in 50 mM sodium phosphate pH 6.8,
with four exchanges over 24 h. Protein determinations were
performed according to the method of Lowry et al. (17) after
solubilizing aliquots of ghosts with .2% sodium dodecyl
sulfate (SDS).1 Absorbance was measured in a Gilford
spectrophotometer (Gilford Instrument Laboratories, Inc.,
Oberlin, Ohio) at 720 nm.
SDS gel electrophoresis. 25 ,ug of erythrocyte membrane
protein was applied to 4% SDS polyacrylamide gels and
electrophoresed according to the method of Fairbanks et al.
(18). The gels were stained with Coomassie Blue, destained
in 10% acetic acid, photographed, and then sliced with
reference to the Coomassie Blue protein bands. The sliced
gels were incubated at 37°C in 1 ml 50% H202 until
completely solubilized and bleached. 10 ml of liquid scintil-
lation fluid (Liquiscint) was added and tritium incorporation
was determined on a Searle Isocap 300 counter (Searle
Radiographics Inc., Des Plaines, Ill.). In some experiments,
the proteins of the erythrocyte membrane were also analyzed
on polyacrylamide gel slabs as described by Laemmli (19).
High-pressure amino acid chromatography. Equivalent
amounts of [3H]sodium borohydride reduced erythrocyte
membrane proteins were hydrolysed in 6 N HCl at 1100C
for 24 h. Amino acids were separated by high-pressure liquid
chromatography on Durrum DC6A (Durrum Instrument
Corp., Sunnyvale, Calif.) cation exchange resin with a pyridine
acetate gradient described previously (7). Recovery of amino
acids in the eluate was monitored by fluorescamine.
Autoradiography. SDS gels were washed twice in 100 ml
dimethyl sulfoxide for 1 h with constant mixing. The gels were
then placed in a mixture of 16 g 2,5-diphenyloxazole and 80 ml
dimethyl sulfoxide for 3 h, and washed in distilled water
for 1 h. The gels were dried and autoradiogrammed for 10 d
at -400C.
Hemoglobin A,, was determined by a modification (7) of the
colorimetric method of Fluckiger and Winterhalter (20),
calibrated by chromatography ofhemoglobin on Biorex 70 ion
exchange resin (Bio-Rad Laboratories, Richmond, Calif.) (21).
RESULTS
The treatment of erythrocyte membranes with [3H]-
borohydride resulted in incorporation of radioactivity
into both proteins and lipid. The various erythrocyte
membrane proteins are effectively separated from
labeled lipid by electrophoresis on SDS gels. As shown
in Table I, comparison of incorporation of radioactivity
into equivalent amounts of erythrocyte membrane pro-
'Abbreviation used in this paper: SDS, sodium dodecyl
sulfate.
tein from diabetic and normal subjects revealed that
diabetic membrane protein consistently incorporated
more tritium than did membrane protein from normal
controls: diabetic/normal 1.9+0.32 SEM; range, 1.5-2.5.
This difference was statistically significant at aP < 0.01
using a simple sign test. Since incorporation of tritium
from rH]BH4 is considered a reliable detector of the
glucosyl-ketoamine linkage these data suggest that
diabetic erythrocyte membrane protein undergoes
greater nonenzymatic glycosylation than that of normal
controls.
To determine the specificity of borohydride incorpo-
ration, equivalent amounts (50 ,ug) of rH]BH4 reduced
membrane protein were subjected to acid hydrolysis
and analyzed by high-pressure liquid chromatography.
In eight analyses, 72±5% of the applied radioactivity
was recovered in the effluent. Fig. IC and D show
representative chromatographic profiles of 3H radio-
activity from a diabetic and a normal subject. The major
radioactive peak eluted from the column at the same
position as synthetic glucosyllysine. In addition, a less
prominent radioactive peak was obtained before the
elution of the glucosyllysine peak. A similar elution
profile was also observed when poly-L-lysine was
incubated with glucose, reduced with [3H]borohydride
and hydrolysed (Fig. IA). Less heterogeneity was
observed on analyses ofhemoglobin A0, which contains
glucosyllysine residues at several sites on both the
a- and ,-chains (7). The radioactive prepeak obtained
on erythrocyte membranes is likely to be a sugar
amino acid adduct, since it adheres to Affi-Gel
601 (boronate gel; Bio-Rad Laboratories, Richmond,
Calif.), a resin with strong affinity for compounds con-
taining vicinal hydroxyl groups. Recent structural
analyses of glycosylated albumin by Day et al. (22)
indicate that the prepeak may be authentic glucosyl-
lysine, whereas the major peak may be a dehydrated
form of glucosyllysine. In contrast to the earlier results
of Bailey et al. (13) we obtained higher yields of
glucosyllysine and better resolution with acid hydroly-
sis than with alkaline hydrolysis.
These results indicate that incorporation of tritiuiii
from [3H]BH4 into erythrocyte membrane proteins is
due primarily to the ketoamine linkage between
glucose and the E-amino of lysine residues. In a com-
parison of four pairs of normals and diabetics, the
amount of radioactivity in the glucosyllysine peak of
the diabetic subjects was 2.2 times that of the normal
controls. These results indicate that diabetic patients
have enhanced nonenzymatic glycosylation primarily
of lysine residues present in the proteins of erythrocyte
membranes.
Erythrocyte membrane proteins were separated on
Steck-Fairbanks SDS gels according to molecular size.
Treatment with borohydride had no effect on the
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TABLE I
Incorporation of [3 H]Borohydride into Erythrocyte Membrane Proteins
Diabetic
Experiment + hemolytic Hemolytic
No. Normals Diabetics anemia anemia
total cpm in membrane proteins*
1 2,200 4,800
2,100 4,500
3,200 5,000
3,600 5,400
2 2,800 4,000
3,100 6,500
3 8,000 24,000
8,000 16,000
4 8,500 25,000
20,000 39,000
5 22,500 37,000
30,000 40,000
26,000 38,000
6 23,000 41,000
26,000 42,500
7 48,000 68,000 55,000 35,000
8 21,000 39,000 30,000 14,000
23,500 41,000 17,000
* Equivalent amounts of normal and diabetic erythrocytes were incubated with
16 mM [3H]borohydride for 40 min. The amount of radioactivity employed varied
between experiments (see text). After exhaustive dialysis, equivalent amounts
(25 gg) of normal and diabetic erythrocyte membrane protein were applied to
SDS gels. After electrophoresis and staining all of the protein bands except hemo-
globin were sliced and counted.
pattern of the stained bands. Examination of autoradio-
grams of these gels revealed incorporation of radio-
activity into each of the bands in approximate pro-
portion to the amount of protein. Quantitation of
borohydride incorporation into the separated proteins
of normals and diabetics is shown in Fig. 2. For
every protein band; the diabetic subjects had greater
tritium incorporation indicating more nonenzymati-
cally glycosylated protein. Thus, the diabetic mem-
branes had increased incorporation compared to the
normal controls without a selective increase in any
one protein band. This conclusion was confirmed by
analysis of pH]borohydride reduced membrane pro-
teins on SDS slab gels as described by Laemmli (19)
(Fig. 3). Even with the enhanced resolution provided
by this method no consistent selectivity in radio-
labeling could be seen in either normal or diabetic
erythrocyte membranes.
To assess the effect of erythrocyte lifespan on the
nonenzymatic glycosylation of erythrocyte membrane
protein, we examined erythrocytes of patients with
hemolytic anemia with and without coexistent dia-
betes. As shown in Fig. 4, patients with uncomplicated
hemolytic anemia had decreased incorporation of
[3H]borohydride into membrane proteins. Those with
diabetes who were studied had the expected increase
and those with coexisting diabetes and hemolysis had
values close to those ofnormals. In all ofthese patients,
there was good correlation between the 3H labeling
of membrane proteins and the corresponding level of
hemoglobin Alc.
DISCUSSION
Nonenzymatic glycosylation of hemoglobin involves
the condensation of two abundant reactants within the
erythrocyte: glucose and hemoglobin. The reaction
takes place slowly and continuously throughout the
cell's 120-d lifespan (23). Initially, this type of
post-translational modification was considered to be
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FicGuRE 1 Elution profile of amino acid mixture obtained by
acid hydrolysis of PH]NaBH4-labeled proteins. A: Poly-L-
lysine incubated with glucose. B: hemoglobin A from diabetic
patient. C: erythrocyte (RBC) membrane from diabetic
patient. D: erythrocyte (RBC) membrane from normal control.
The ghosts from normal and diabetic erythrocytes were
incubated with identical amounts of labeled borohydride and
identical amounts of hydrolysed proteins were applied to the
cation exchange column.
specific for the NH2-terminal amino group of the
,8-chain. Recently, however, it has become clear that
glucose forms similar ketoamine linkages with a num-
ber of other amino groups in hemoglobin including
the NH2-terminal amino group of the a-chain as well
as several lysine residues on both the a- and the
p-chains (7, 24) (f3-Lys 66, a-Lys 61, ,-Lys 17, and
a-Lys 40). The broader range of reactive sites on
hemoglobin raises the question of whether other pro-
teins are modified in a similar fashion.
The extent of nonenzymatic glycosylation of hemo-
globin in vivo depends upon two independent varia-
bles: the average blood glucose concentration over the
preceding 2-3 mo and the lifespan of the erythrocyte.
Accordingly, glycosylated hemoglobin is increased in
patients with diabetes and decreased in those with
hemolysis (23, 25). The results presented here show
that these two factors apply equally well to the non-
enzymatic glycosylation of erythrocyte membrane pro-
teins. Like hemoglobin, the proteins ofthe erythrocyte
membrane are synthesized during erythropoiesis in the
bone marrow and remain intact, with negligible turn-
over, throughout the cell's lifespan. We have shown
that most if not all the membrane proteins separable
on SDS gels are modified by ketoamine linkages with
glucose. It was of interest to determine if any protein
bands were preferentially labeled with borohydride.
A possible candidate would be band 4.5, a protein
which appears to be responsible for the facilitated
diffusion of glucose across the erythrocyte membrane
(26, 27). Therefore the transmembrane segment of this
molecule would be expected to have enhanced contact
with glucose. However no clear-cut preferential label-
ing was observed. According to current understanding
of the structure of the erythrocyte membrane (28)
certain proteins such as the anion channel (band 3) and
glycophorin span the lipid bilayer, whereas others such
as spectrin (bands 1 and 2), actin (band 5), and ankyrin
(band 2.1) form a lattice that laminates the cytoplasmic
surface of the lipid bilayer. Charged residues on these
proteins such as lysine are likely to be exposed
to the aqueous solvent on either the outer or inner
surface of the membrane and should be exposed to
nearly equivalent concentrations of glucose. Nonenzy-
matic glycosylation may also involve other residues,
particularly at the NH2-terminus where the pK of the
amino group is significantly lower than the E-amino of
lysine. Our amino acid analyses do not permit the
identification of other glycosylated residues.
This study as well as the structural analysis of hemo-
globin cited above (7, 24) depends on the use of [3H]-
borohydride to identify ketoamine linkages. At neutral
pH, borohydride has a high degree of specificity for
aldehyde and ketone groups, converting them to the
corresponding alcohols. The reagent is not reactive
with esters, lactones, amides, or acid carbonyl groups.
In acidic media borohydride can reduce indoles (29).
Furthermore, under certain conditions, fatty acid esters
can be reduced to fatty alcohols (30). As shown in Fig. 4,
Nonenzymatic Glycosylation of Membrane Protein
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FIGURE 2 Comiparison of radioactivity of proteini bands from erythrocytes of three normiial indi-
vi(luals (cross-hatchedl bars) and three diabetic patients (stippled bars). Fresh blood samples were
collected on the saime day. Equivalent aimounts of [3H]NaBH4 was added to each ghost preparation
(Table I, experiimient 5). The ranige of raldioactivity valuies is shown for each band.
we did observe considerable incorporation of' radio-
activity into membrane lipids which were readily
separable from proteins by electrophoresis oIn SDS
gels. The fact that we obtainied a high yield of
glucosyllysine from preparation of [3H]borohydride re-
duced membrane protein attests to the specificity of
the reagent under the experimiiental conditions that
were employed.
Our results indicate that enhancement of nonenzy-
inatic glycosylation in diabetics extends beyond hemo-
globin to the proteins of the erythrocyte membranie.
This phenomenon may have functional significance.
Recently Peterson et al. (31) have shown that diabetics
have a nmoderately shortened erythrocyte survival,
which is corrected by the inistittution of rigid control.
Furthermiore, McMillan et al. (32) have dernonstrated
that diabetic erythrocytes are less deformable than nor-
mal when drawn into a 2-,um capillary pipette. It is
uncertain whether the abnormal rheology of' the
imembrane in diabetic erythrocytes is due to alterations
in the composition of lipids in the bilayer or perhaps
to post-translational modification of memibranie proteins.
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